US4532244A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Method of treating migraine headaches
Assignee: Individual
•
Filing: 1984-09-06
•
Granted: 1985-07-30
•
Expires: 2004-09-06
Abstract
Abstract Migraine headaches are treated or prevented by the administration of scopolamine or a pharmaceutically acceptable salt thereof. Preferably scopolamine hydrocloride is administered to the patient transdermally at a substantially constant rate using a metered drug delivery system conveniently adhered to the patient's skin.
Inventors
- 👤 Margaret N. Innes
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-07 08:34
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/33; A61K31/395; A61K31/435; A61K31/46; A61P; A61P25/00; A61P25/04
Claims Analysis
Total Claims: 8
Claim 1
Independent Claim
32 words
A method for treating migraine comprising administering to a person suffering therefrom a symptom-alleviating amount of scopolamine or a pharmaceutically acceptable salt thereof and continuing said administration until the symptoms are alleviated.
Claim 2
Independent Claim
32 words
A method for treating migraine comprising administering to a person suffering therefrom a symptom-alleviating amount of scopolamine or a pharmaceutically acceptable salt thereof and continuing said administration until the symptoms are alleviated.
Claim 3
Dependent Claim
23 words
The method of claim 1 in which the scopolamine or a pharmaceutically acceptable salt thereof is administered transdermally at a substantially constant rate.
Claim 4
Dependent Claim
40 words
The method of claim 2 in which the scopolamine or a pharmaceutically acceptable salt thereof is delivered at a substantially constant rate to the person's systemic circulation in an amount of about 0.5 mg over a period of 72 hours.
Claim 5
Independent Claim
44 words
A method of preventing severe migraine attack in a person susceptible to same comprising administering to said person a prophylactically effective amount of scopolamine or a pharmaceutically acceptable salt thereof and continuing said administration until susceptibility to migraine attack is diminished or is removed.
Claim 6
Independent Claim
44 words
A method of preventing severe migraine attack in a person susceptible to same comprising administering to said person a prophylactically effective amount of scopolamine or a pharmaceutically acceptable salt thereof and continuing said administration until susceptibility to migraine attack is diminished or is removed.
Claim 7
Dependent Claim
23 words
The method of claim 4 in which the scopolamine or a pharmeceutically acceptable salt thereof is administered transdermally at a substantially constant rate.
Claim 8
Dependent Claim
40 words
The method of claim 4 in which the scopolamine or a pharmaceutically acceptable salt thereof is delivered at a substantially constant rate to the person's systemic circulation in an amount of about 0.5 mg over a period of 72 hours.
References Cited (Backward Citations)
US2276677A
Cited
US3865933A
Cited
US3888975A
Cited
US3993057A
Cited
US4026290A
Cited
US4070463A
Cited
US4201211A
Cited
US4369172A
Cited
US4389393A
Cited
US4389393B1
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1988-07-29 | 1989-01-28 | 1989-07-30 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1992-07-29 | 1993-01-28 | 1993-07-30 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1996-07-29 | 1997-01-28 | 1997-07-30 | $7700.00 | Window Closed / Lapsed |